Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine vs Hyalase for Failed Back Surgery Syndrome
NCT05370963Phase 1Completed
- Sponsor
- Minia University
- Start
- May 2022
- Primary completion
- May 2023
- Modality
- Therapeutic Enzymes, Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of dexmedetomidine and hyaluronidase in failed back surgery syndrome (FBSS), sponsored by Minia University. Primary endpoint: Pain Assessment at 6 months. Started May 2022; status: completed.
02
Drugs
dexmedetomidinehyaluronidase
03
Conditions
failed back surgery syndrome (FBSS)
Beyond the preview
Go deeper on NCT05370963.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05370963.